Literature DB >> 22348294

An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.

Eylem Sercan Ozgür1, Sibel Atiş Nayci, Cengiz Özge, Bahar Taşdelen.   

Abstract

BACKGROUND: Dynamic hyperinflation (DH) and exercise limitation develop in patients with COPD; however, there is lack of knowledge about their long-term clinical consequences. We aimed to assess the impact of DH and exercise capacity in predicting mortality and also morbidity, as evaluated by emergency visits and hospital admissions in COPD patients during a 4-year period.
METHODS: We recruited 73 stable COPD patients. The relationships of different respiratory parameters (FEV(1)%, body mass index, 6 min walk test distance [6MWD], static hyperinflation as measured by the ratio of inspiratory capacity to total lung capacity (IC/TLC) at rest, DH as measured by the change between the post- and pre-exercise values of IC/TLC [ΔIC/TLC], P(aO(2)), and P(aCO(2))) with emergency visits and hospital admissions because of exacerbations and also with respiratory and all-cause mortality were assessed.
RESULTS: The median follow-up period was 47 months (IQR 45-48 months, n = 73). During the follow-up there were 8 (11%) deaths. The ΔIC/TLC value was 3.9 ± 4.6%. The Kaplan-Meier survival curve showed that the cumulative survival rate was significantly lower in the patients with ΔIC/TLC > 4 and with 6MWD ≤ 439.56 m, using these values as thresholds. (The rates for sensitivity were 100% and 87.5%, and for specificity were 56.92% and 87.69%, respectively). The Cox proportional hazards model showed that DH (hazard ratio = 1.4, 95% CI = 1.09-1.84, P = .009) and 6MWD (hazard ratio = 0.98, 95% CI = 0.97-0.99, P = .006) were independent predictors of all-cause and respiratory mortality. 6MWD, FEV(1)%, IC/TLC, and ΔIC/TLC were found to be significantly related to emergency visits (r = -0.28, r = -0.41, r = -0.24, and r = 0.38, respectively) and hospital admissions (r = -0.41, r = -0.45, r = -0.36, and r = 0.28, respectively).
CONCLUSIONS: DH and exercise capacity are reliable and independent predictors for mortality and morbidity in COPD patients. We propose that DH and exercise capacity be considered in the assessment of long-term clinical consequences of COPD patients. Copyright 2012 Daedalus Enterprises

Entities:  

Mesh:

Year:  2012        PMID: 22348294     DOI: 10.4187/respcare.01440

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  5 in total

Review 1.  Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Martin Bell; Iain Fotheringham; Yogesh Suresh Punekar; John H Riley; Sarah Cockle; Sally J Singh
Journal:  Chronic Obstr Pulm Dis       Date:  2015-07-08

2.  Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.

Authors:  Kai M Beeh; Dave Singh; Lilla Di Scala; Anton Drollmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-31

3.  The predictive value of an adjusted COPD assessment test score on the risk of respiratory-related hospitalizations in severe COPD patients.

Authors:  Joanne M Sloots; Christopher A Barton; Julie Buckman; Katherine L Bassett; Job van der Palen; Peter A Frith; Tanja W Effing
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

4.  Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.

Authors:  Jilles M Fermont; Katya L Masconi; Magnus T Jensen; Renata Ferrari; Valéria A P Di Lorenzo; Jacob M Marott; Philipp Schuetz; Henrik Watz; Benjamin Waschki; Hana Müllerova; Michael I Polkey; Ian B Wilkinson; Angela M Wood
Journal:  Thorax       Date:  2019-01-07       Impact factor: 9.139

5.  Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

Authors:  Sally Singh; François Maltais; Lee Tombs; William A Fahy; Mitra Vahdati-Bolouri; Nicholas Locantore; John H Riley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.